• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Clin Microbiol Infect Dis . Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospec

tetano

Editor, Senior Moderator
Eur J Clin Microbiol Infect Dis


. 2021 Jan 15;1-8.
doi: 10.1007/s10096-020-04151-9. Online ahead of print.
Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study


Lei Pan[SUP] #[/SUP][SUP] 1 [/SUP], Runsheng Wang[SUP] #[/SUP][SUP] 2 [/SUP], Na Yu[SUP] #[/SUP][SUP] 3 [/SUP], Chao Hu[SUP] #[/SUP][SUP] 2 [/SUP], Junhong Yan[SUP] 4 [/SUP], Xiaomin Zhang[SUP] 5 [/SUP], Tao Wang[SUP] 1 [/SUP], Jungui Hao[SUP] 6 [/SUP], Fuquan Gao[SUP] 1 [/SUP], Tonggang Liu[SUP] 7 [/SUP], Jing Wang[SUP] 1 [/SUP], Xiaojing Liu[SUP] 1 [/SUP], Mi Mu[SUP] 8 [/SUP], Wei Huang[SUP] 9 [/SUP], Yongzhong Guo[SUP] 10 [/SUP], Changjun Lv[SUP] 1 [/SUP], Xiaozhi Wang[SUP] #[/SUP][SUP] 11 [/SUP], Lei Tu[SUP] #[/SUP][SUP] 12 [/SUP], Kun Wan[SUP] #[/SUP][SUP] 13 [/SUP], Guogang Xu[SUP] #[/SUP][SUP] 14 [/SUP]



Affiliations

Abstract

At present, it has been noticed that some patients recovered from COVID-19 present a recurrent positive RNA test of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) after being discharged from hospitals. The purpose of the current study was to characterize the clinical features of re-hospitalized patients with recurrent SARS-CoV-2 positive results. From January 12 to April 1 of 2020, our retrospective study was conducted in China. The exposure history, baseline data, laboratory findings, therapeutic schedule, and clinical endpoints of the patients were collected. All the patients were followed until April 10, 2020. Among all COVID-19 patients included in the current study, there were 14 re-hospitalized patients due to recurrent positive tests of SARS-CoV-2 RNA. Fever (11 [78.6%]), cough (10 [71.4%]), and fatigue (7 [50.0%]) were the most common symptoms on the patient's first admission, and less symptoms were found on their second admission. The average duration from the onset of symptoms to admission to hospital was found to be 8.4 days for the first admission and 2.6 days for the second admission (P = 0.002). The average time from the detection of RNA (+) to hospitalization was 1.9 days for the first admission and 2.6 days for the second admission (P = 0.479), and the average time from RNA (+) to RNA (-) was 11.1 days for the first admission and 6.3 days for the second admission (P = 0.030). Moreover, the total time in hospital was 18.6 days for the first admission and 8.0 days for the second admission (P = 0.000). It may be necessary to increase the isolation observation time and RT-PCR tests should be timely performed on multiple samples as soon as possible.

Keywords: COVID-19; Management; Outcome; Re-hospitalization; SARS-CoV-2.
 
Back
Top Bottom